China

Index
Media OutReach

Coface Asia Corporate Payment Survey 2023: Asian Companies Experience Fewer Payment Felays and Are Rather Optimistic Despite Multiple Headwinds Ahead

Globenewswire

Junshi Biosciences Announces Initiation of Phase 3 Study of Tifcemalimab plus Toripalimab for Treatment of Limited-stage Small Cell Lung Cancer